1-10 of 10
Amir Abdollahi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580

Valentina Fermi, Rolf Warta, Amélie Wöllner, Catharina Lotsch, Lena Jassowicz, Carmen Rapp, Maximilian Knoll, Gerhard Jungwirth, Christine Jungk, Philip Dao Trong, Andreas von Deimling, Amir Abdollahi, Andreas Unterberg, Christel Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (22): 4685–4697.
https://doi.org/10.1158/1078-0432.CCR-23-0576
Published: 14 November 2023
View article titled, Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580
Open the PDF for Effective Reprogramming of Patient-Derived M2-Polarized Glioblastoma-Associated Microglia/Macrophages by Treatment with GW2580 in another window
Includes: Supplementary data
Journal Articles

DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy

Bouchra Tawk, Katrin Rein, Christian Schwager, Maximilian Knoll, Ute Wirkner, Juliane Hörner-Rieber, Jakob Liermann, Ina Kurth, Panagiotis Balermpas, Claus Rödel, Annett Linge, Steffen Löck, Fabian Lohaus, Ingeborg Tinhofer, Mechtild Krause, Martin Stuschke, Anca Ligia Grosu, Daniel Zips, Stephanie E. Combs, Claus Belka, Albrecht Stenzinger, Christel Herold-Mende, Michael Baumann, Peter Schirmacher, Jürgen Debus, Amir Abdollahi
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (16): 3051–3064.
https://doi.org/10.1158/1078-0432.CCR-22-3790
Published: 15 August 2023
View article titled, DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
Open the PDF for DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy in another window
Includes: Supplementary data
Journal Articles

Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas

Gerhard Jungwirth, Tao Yu, Fang Liu, Junguo Cao, Montadar Alaa Eddine, Mahmoud Moustafa, Amir Abdollahi, Rolf Warta, Andreas Unterberg, Christel Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (1): 233–243.
https://doi.org/10.1158/1078-0432.CCR-22-2085
Published: 04 January 2023
View article titled, Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas
Open the PDF for Pharmacological Landscape of FDA-Approved Anticancer Drugs Reveals Sensitivities to Ixabepilone, Romidepsin, Omacetaxine, and Carfilzomib in Aggressive Meningiomas in another window
Includes: Supplementary data
Journal Articles

Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival

Kolja Pocha, Andreas Mock, Carmen Rapp, Steffen Dettling, Rolf Warta, Christoph Geisenberger, Christine Jungk, Leila R. Martins, Niels Grabe, David Reuss, Juergen Debus, Andreas von Deimling, Amir Abdollahi, Andreas Unterberg, Christel C. Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (9): 2231–2243.
https://doi.org/10.1158/1078-0432.CCR-19-2184
Published: 01 May 2020
View article titled, Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival
Open the PDF for Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival in another window
Includes: Supplementary data
Journal Articles

Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

Carmen Rapp, Steffen Dettling, Fang Liu, Anna Theresa Ull, Rolf Warta, Christine Jungk, Saskia Roesch, Andreas Mock, Felix Sahm, Melissa Schmidt, Gerhard Jungwirth, Klaus Zweckberger, Katrin Lamszus, Konstaninos Gousias, Almuth F. Kessler, Niels Grabe, Mario Loehr, Ralf Ketter, Steffi Urbschat, Christian Senft, Manfred Westphal, Amir Abdollahi, Juergen Debus, Andreas von Deimling, Andreas Unterberg, Matthias Simon, Christel C. Herold-Mende
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (17): 5260–5270.
https://doi.org/10.1158/1078-0432.CCR-19-0389
Published: 03 September 2019
View article titled, Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas
Open the PDF for Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas in another window
Includes: Supplementary data
Journal Articles

The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

David Digomann, Ina Kurth, Anna Tyutyunnykova, Oleg Chen, Steffen Löck, Ielizaveta Gorodetska, Claudia Peitzsch, Ira-Ida Skvortsova, Giulia Negro, Bertram Aschenbrenner, Graeme Eisenhofer, Susan Richter, Stephan Heiden, Joseph Porrmann, Barbara Klink, Christian Schwager, Adam A. Dowle, Linda Hein, Leoni A. Kunz-Schughart, Amir Abdollahi, Fabian Lohaus, Mechthild Krause, Michael Baumann, Annett Linge, Anna Dubrovska
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (10): 3152–3163.
https://doi.org/10.1158/1078-0432.CCR-18-2951
Published: 15 May 2019
View article titled, The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity
Open the PDF for The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity in another window
Includes: Supplementary data
Journal Articles

Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy

Stefan Schmidt, Annett Linge, Alex Zwanenburg, Stefan Leger, Fabian Lohaus, Constanze Krenn, Steffen Appold, Volker Gudziol, Alexander Nowak, Cläre von Neubeck, Inge Tinhofer, Volker Budach, Ali Sak, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Hatice Bunea, Anca-Ligia Grosu, Amir Abdollahi, Jürgen Debus, Ute Ganswindt, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, David Mönnich, Daniel Zips, Gustavo B. Baretton, Frank Buchholz, Michael Baumann, Mechthild Krause, Steffen Löck
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1364–1374.
https://doi.org/10.1158/1078-0432.CCR-17-2345
Published: 14 March 2018
View article titled, Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy
Open the PDF for Development and Validation of a Gene Signature for Patients with Head and Neck Carcinomas Treated by Postoperative Radio(chemo)therapy in another window
Includes: Supplementary data
Journal Articles

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

Annett Linge, Steffen Löck, Volker Gudziol, Alexander Nowak, Fabian Lohaus, Cläre von Neubeck, Martin Jütz, Amir Abdollahi, Jürgen Debus, Inge Tinhofer, Volker Budach, Ali Sak, Martin Stuschke, Panagiotis Balermpas, Claus Rödel, Melanie Avlar, Anca-Ligia Grosu, Christine Bayer, Claus Belka, Steffi Pigorsch, Stephanie E. Combs, Stefan Welz, Daniel Zips, Frank Buchholz, Daniela E. Aust, Gustavo B. Baretton, Howard D. Thames, Anna Dubrovska, Jan Alsner, Jens Overgaard, Michael Baumann, Mechthild Krause
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (11): 2639–2649.
https://doi.org/10.1158/1078-0432.CCR-15-1990
Published: 31 May 2016
View article titled, Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG
Open the PDF for Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG in another window
Includes: Supplementary data
Journal Articles

Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy

Carmen Timke, Heike Zieher, Alexandra Roth, Kai Hauser, Kenneth E. Lipson, Klaus J. Weber, Jürgen Debus, Amir Abdollahi, Peter E. Huber
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (7): 2210–2219.
https://doi.org/10.1158/1078-0432.CCR-07-1893
Published: 01 April 2008
View article titled, Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy
Open the PDF for Combination of Vascular Endothelial Growth Factor Receptor/Platelet-Derived Growth Factor Receptor Inhibition Markedly Improves Radiation Tumor Therapy in another window
Journal Articles

Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy

Amir Abdollahi, David W. Griggs, Heike Zieher, Alexandra Roth, Kenneth E. Lipson, Rainer Saffrich, Hermann-Josef Gröne, Dennis E. Hallahan, Ralph A. Reisfeld, Juergen Debus, Andreas G. Niethammer, Peter E. Huber
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6270–6279.
https://doi.org/10.1158/1078-0432.CCR-04-1223
Published: 06 September 2005
View article titled, Inhibition of α<sub>v</sub>β<sub>3</sub> Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy
Open the PDF for Inhibition of α<sub>v</sub>β<sub>3</sub> Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy in another window